Developing Countries: Human Papillomavirus:Written question - HL6184

Asked on: 20 March 2017
Department for International Development
Developing Countries: Human Papillomavirus
To ask Her Majesty’s Government what priority they give to HPV vaccination in developing country programmes.
Answered by: Lord Bates
Answered on: 28 March 2017

The UK’s assessment is that the most effective approach to vaccinate all girls in developing countries against HPV is through Gavi, the Vaccine Alliance. Gavi will vaccinate 40 million girls against HPV and prevent 900,000 deaths by 2020. The UK is the largest contributor to Gavi, and UK funds will vaccinate over 10 million girls against HPV by 2020, preventing over 200,000 future deaths from cervical cancer.

DFID supports low income countries to strengthen their health services, so that they can effectively address the existing disease burden and be responsive to the future and changing health needs.

Share this page